"oxaliplatin l\u00E9\u010Div\u00E1 l\u00E1tka"@cs . . "Ka\u010Der, Petr" . . . "Mengler, Jan" . . "http://www.vuabpharma.cz" . . . "[CAB6F44963C3]" . "Havlovic, Karel" . "oxaliplatin l\u00E9\u010Div\u00E1 l\u00E1tka" . "oxaliplatin"@en . . . "P(2A-2TP1/049)" . . "Oxaliplatin API VUAB Pharma" . "3"^^ . . "oxaliplatin l\u00E9\u010Div\u00E1 l\u00E1tka"@cs . . . . . . . "RIV/63078180:_____/12:#0000005!RIV12-MPO-63078180" . "oxaliplatin active pharmaceutical ingredient"@en . "oxaliplatin l\u00E9\u010Div\u00E1 l\u00E1tka, CAS No. [61825-94-3 ], podle evropsk\u00E9ho a americk\u00E9ho l\u00E9kopisu"@cs . "ro\u010Dn\u00ED zv\u00FD\u0161en\u00ED objemu v\u00FDroby za rok 2011 o 1 mil. K\u010D" . "157535" . . "Kysilka, Vladim\u00EDr" . "oxaliplatin API , CAS No. [61825-94-3 ], according to European Pharmacopoeia and US Pharmacopoeia"@en . "oxaliplatin active pharmaceutical ingredient"@en . "\u010Cerven\u00FD, Libor" . "5"^^ . "VUAB Pharma" . "oxaliplatin l\u00E9\u010Div\u00E1 l\u00E1tka" . "Jakostn\u00ED limity dle analytick\u00E9 specifikace oxaliplatiny API VUAB Pharma; V\u00FDsledek byl vyroben na z\u00E1klad\u011B ov\u011B\u0159en\u00ED (testov\u00E1n\u00ED) vlastnost\u00ED. V\u00FDsledek je vyu\u017E\u00EDv\u00E1n p\u0159\u00EDjemcem na z\u00E1klad\u011B Smlouvy o vyu\u017E\u00EDt\u00ED v\u00FDsledk\u016F v\u00FDzkumu a v\u00FDvoje 2011/2A-2TP1/049 ze dne 31.8.2011." . . "oxaliplatin l\u00E9\u010Div\u00E1 l\u00E1tka, CAS No. [61825-94-3 ], podle evropsk\u00E9ho a americk\u00E9ho l\u00E9kopisu" . "RIV/63078180:_____/12:#0000005" . .